A patent gives a drugmaker exclusive rights to manufacture a vaccine
it developed, also providing it the power to charge a price that
covers the costs of research and development. Their profit margin per
dose, however, depends on the urgency of the situation, and amid a
pandemic, charging anything more than development costs is bound to be
controversial.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/vaccinating-billions-means-finding-ways-around-a-patent-impasse/articleshow/79754115.cms
No comments:
Post a Comment